The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary ...
China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...
It’s a question that some users of semaglutide and tirzepatide injections, sold as Wegovy and Zepbound for weight loss, have ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
Meaning, whether you lose weight through a change in your diet, a different medication, or bariatric surgery, there is a risk ...
Management Services Organization (MSO) IntraCare and intermittent fasting app MogulBody have joined forces to create MogulBodyCare, LLC. The new company takes a multidirectional approach to weight ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback